Life Sciences Investor Forum today announced that the presentations from the September 16 th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.

This virtual event showcased live executive presentations and interactive discussions focused on publicly traded companies in the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company’s “virtual trade booth”.


REGISTER OR LOGIN AT: https://bit.ly/3hFx0MB

September 16 th Presenting Companies:

Presenting Company Ticker(s)
VolitionRx Limited NYSE AMERICAN: VNRX
Avicanna Inc. ( OTCQX: AVCNF | TSX: AVCN)
Alpha Cognition Inc. OTCQB: ACOGF | TSX-V: ACOG
Willow Biosciences Inc. ( OTCQX: CANSF | TSX: WLLW)
Filament Health Corp. ( Pink: FLHLF | NEO: FH)
Novamind Inc. ( OTCQB: NVMDF | CSE: NM)
Salarius Pharmaceuticals, Inc. Nasdaq: SLRX
MedX Health Corp. TSX-V: MDX
Wesana Health Holdings Inc. ( OTCQB: WSNAF | CSE: WESA)
Compass Therapeutics, Inc. OTCQB: CMPX
Else Nutrition Holdings Inc. ( OTCQX: BABYF | TSX-V: BABY)

To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com .

About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

CONTACT
Life Sciences Investor Forum
John M. Viglotti
SVP Corporate Services, Investor Access
(212) 220-2221
johnv@lifesciencesinvestorforum.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in two upcoming events hosted by Microdose:

  • Psychedelic Capital to be held virtually on Thursday, October 28, 2021 . Payton Nyquvest , Founder and CEO of Numinus, will present at 1:45 p.m. ET . To attend, please register here .
  • Wonderland: Miami to be held at the Adrienne Arsht Center for the Performing Arts in Miami, FL on November 8-9, 2021 . Mr. Nyquvest and Dr. Evan Lewis , Founder & Director of the Neurology Centre of Toronto , will give a presentation called Psychedelic Neurology in the Treatment of Trauma on Monday, November 8 at 4:40 p.m. ET . In addition, Sharan Sidhu , Science Officer & General Manager of Numinus, will participate in the Patent Wars panel on Tuesday, November 9 at 4:30 p.m. ET . To attend, please register here .

For more information about the events or to schedule a one-on-one meeting with Numinus‘ management, please contact KCSA Strategic Communications at NuminusIR@kcsa.com .

Keep reading... Show less

Florida’s leading cannabis company to open three new Miami dispensaries

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), the largest multi-state operator (MSO) in the United States today announced the reopening of three medical marijuana dispensaries in Miami, Florida . The locations were formerly branded as Harvest House of Cannabis.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today the opening of a new Sunnyside dispensary in Tallahassee, Florida. Tallahassee is Cresco Labs’ first location in the Panhandle, 10 th in Florida and 39 th nationwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211026005417/en/

Keep reading... Show less

Ayurcann Holdings Corp. (CSE: AYUR) (FSE:3ZQ0) (the “ Company ” or “ Ayurcann ”) a Canadian cannabis extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is pleased to announce that it has entered into a patient-referral agreement with The Herb Clinic (“ Clinic ”), providing Canadians guidance and access to managing discomfort with medicinal cannabis.

The Herb Clinic has over 4000 patients registered and is comprised of compassionate and knowledgeable service providers who are defined by their ability to provide exceptional patient care. They help educate and integrate cannabis into the patient’s medical treatment plans and partner with medicinal cannabis providers such as Ayurcann, to ensure their patients are getting top-quality advice with exceptional value.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today its “Summer of Social Justice” nationwide initiative raised over $250,000 for social justice-focused community organizations and supported the expungement process for over 1,000 individuals with cannabis-related criminal records.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211025005254/en/

Keep reading... Show less